Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Walgreens Boots Alliance leverages Rule 144 to sell Cencora shares

EditorPollock Mondal
Published 10/11/2023, 08:18
© Reuters.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has disclosed its use of Rule 144 of the Securities Act of 1933 to sell shares of Cencora, Inc. through variable prepaid forward transactions. The sale, which took place on Thursday, resulted in immediate proceeds of approximately $424 million for the company, with potential for additional returns depending on Cencora's stock performance.

In tandem with the sale, Walgreens also conducted a share repurchase from Cencora, valued at around $250 million. Despite these financial maneuvers, Walgreens' ownership stake in Cencora remains at an estimated 15%. The transactions not only provided instant liquidity but also ensured Walgreens' voting and dividend rights in Cencora.

The variable prepaid forward contracts are set to mature in Q4 of fiscal year 2026. At that time, Walgreens plans to transfer 2.7 million shares of Cencora common stock to the contract counterparties. Depending on the prevailing stock price at the time of settlement, Walgreens could receive additional proceeds up to $137 million.

The proceeds from these transactions will be primarily allocated towards debt reduction and other general corporate purposes. This strategic move is part of Walgreens' effort to streamline its portfolio and enhance cash management.

The sale does not impact the ongoing partnership between Walgreens and Cencora that was established in 2013. Ornella Barra, COO International of WBA, will continue her role on Cencora’s Board of Directors.

Walgreens Boots Alliance is an integrated healthcare, pharmacy, and retail leader serving millions globally. Operating in eight countries, it employs approximately 330,000 individuals.

InvestingPro Insights

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Walgreens Boots Alliance (WBA) is demonstrating a promising financial outlook according to InvestingPro's real-time data and insights. The company is showing a notable revenue growth of 4.81% in the last twelve months as of Q4 2023. In addition, with a market capitalization of 17.67B USD, WBA remains a prominent player in the Consumer Staples Distribution & Retail industry.

InvestingPro Tips suggest that WBA has a strong history of maintaining dividend payments, having done so for 53 consecutive years. This consistent return to shareholders, coupled with the fact that WBA is trading near its 52-week low, could make it an attractive option for dividend-focused investors.

Furthermore, InvestingPro's data indicates a high shareholder yield and a promising P/E Ratio (Adjusted) of 10.27 as of Q4 2023. This, along with the fact that WBA's net income is expected to grow this year, suggests potential for future profitability. However, prospective investors should also note that 6 analysts have recently revised their earnings predictions downwards for the upcoming period.

In total, InvestingPro offers over 13 additional tips for WBA, providing a comprehensive tool for investors to make informed decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.